NL-OMON44485已完成不适用
A single-center, open-label, single oral dose study to investigate the absorption, distribution, metabolism, and excretion (ADME) and pharmacokinetics of EMA401 after a single dose of [14C]EMA401 in healthy male subjects - EMA401 human ADME study in healthy male subjects
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- healthy male subjects
- •- 40-55 yrs, inclusive
- •- BMI: 18.0-30.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study. Donation or loss of 50 mL or more of blood within eight weeks prior to initial dosing, or longer if required by local regulation.
研究者
相似试验
进行中（未招募）
不适用
A clinical trial to evaluate the effects of food on the bioavailability of CKD-397 in healthy male subjectsDiseases of The genitoruinary systemKCT0001862Chong Kun Dang16
已完成
1 期
A single dose study in healthy Japanese participants to evaluate the safety and pharmacokinetics of otilimab.Rheumatoid ArthritisJPRN-jRCT2071210132Yamada Masanori12
已完成
不适用
A clinical trial to compare safety and pharmacokinetic characteristics of CKD-337KCT0001787Chong Kun Dang48
进行中（未招募）
1 期
A study designed to investigate how radiolabelled RPC1063 is taken up, broken down and removed from the bodyThe drug is a potential treatment for adult patients with relapsing multiple sclerosis (RMS) and for adult patients with moderately to severely active inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD).MedDRA version: 19.0 Level: PT Classification code 10028245 Term: Multiple sclerosis System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: LLT Classification code 10045365 Term: Ulcerative colitis System Organ Class: 100000004856MedDRA version: 19.0 Level: LLT Classification code 10013099 Term: Disease Crohns System Organ Class: 100000004856EUCTR2016-003073-18-GBCelgene International II Sàrl6
尚未招募
不适用
An Open-label, Parallel, Single-Dose, Clinical Study after administration of WS1313D in Children and Adolescent with Pain to Evaluate Pharmacokinetics (PK) / Pharmacodynamics (PD) and SafetyKCT0004166Woosung Pharma62